ERBB2 and neoplasm: Human epidermal growth factor receptor 2 (HER2) gene amplification occurs in 13–22% of MC cases, characterized by increased proliferation, tumor growth and metastatic potential [2, 3], contributing to aggressive behavior with an unfavorable clinical prognosis.